The latest version of California’s proposed prescription drug formulary includes a provision for peri-operative prescribing, in which doctors can prescribe without prospective review drugs that are ordinarily considered “non-preferred” to a patient undergoing surgery.
The peri-operative exemption applies primarily to opioids and anti-coagulant drugs, according to Dr. Ray Meister, executive medical director for the Division of Workers’ Compensation. Meister presented a webinar on Thursday on DWC’s medical treatment utilization schedule, or MTUS, and the propos...
Comments